Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Human foreskin fibroblast–conditioned medium improved hair growth in androgenetic alopecia patients.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Some immunosuppressed patients can get unusual skin infections from Malassezia, which can be treated with antifungal medication.

ALDOA levels drop in hair cells during hair loss.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

A peptide from hair follicle stem cells can boost hair growth.

BTA safely and effectively treats hair loss, and works better with FNS.

Oral griseofulvin for 6-12 weeks cures most scalp fungal infections in children.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

The new assay can help develop products for hair re-growth.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

The formulated gel is a promising treatment for alopecia areata.

Iron contributes to skin fibrosis in nephrogenic systemic fibrosis.

Sorafenib may cause hair loss in a way similar to alopecia areata.

The growth factor cocktail significantly increased hair growth in patients with androgenetic alopecia.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

The lotion helps manage mild to moderate hair loss.

Topical treatment with amphotericin B and DMSO effectively healed a horse's skin infection.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

N1-acetylspermidine promotes hair follicle stem cell self-renewal.

Finasteride is considered to have a low risk to fetuses.

Clofazimine effectively treated ashy dermatosis in a patient.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Epidermal growth factor helps hair recover after chemotherapy.

Finasteride delivery through skin improved using invasomes and iontophoresis.